Evidence map›Paper›PMID 35648332›Full record

ReviewCerebellum (London, England)2023

ANO10 Function in Health and Disease.

Androniki Chrysanthou, Antonis Ververis, Kyproula Christodoulou

Open access · hybridAbstract readReview
In one paragraph

Review in Cerebellum (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. TMEM16 proteins: CaInternational journal of molecular medicine · 2024
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Androniki ChrysanthouNeurogenetics Department, The Cyprus Institute of Neurology and Genetics, Iroon Avenue 6, Agios Dometios 2371, Nicosia, Cyprus.ORCID http://orcid.org/0000-0002-8978-7326
Antonis VerverisNeurogenetics Department, The Cyprus Institute of Neurology and Genetics, Iroon Avenue 6, Agios Dometios 2371, Nicosia, Cyprus.ORCID http://orcid.org/0000-0002-6419-0566
Kyproula ChristodoulouNeurogenetics Department, The Cyprus Institute of Neurology and Genetics, Iroon Avenue 6, Agios Dometios 2371, Nicosia, Cyprus. roula@cing.ac.cy.ORCID http://orcid.org/0000-0002-0622-7594
Cyprus Institute of Neurology and Genetics · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anoctamin 10 (ANO10), also known as TMEM16K, is a transmembrane protein and member of the anoctamin family characterized by functional duality. Anoctamins manifest ion channel and phospholipid scrambling activities and are involved in many physiological processes such as cell division, migration, apoptosis, cell signalling, and developmental processes. Several diseases, including neurological, muscle, blood disorders, and cancer, have been associated with the anoctamin family proteins. ANO10, which is the main focus of the present review, exhibits both scrambling and chloride channel activity; calcium availability is necessary for protein activation in either case. Additional processes implicating ANO10 include endosomal sorting, spindle assembly, and calcium signalling. Dysregulation of calcium signalling in Purkinje cells due to ANO10 defects is proposed as the main mechanism leading to spinocerebellar ataxia autosomal recessive type 10 (SCAR10), a rare, slowly progressive spinocerebellar ataxia. Regulation of the endolysosomal pathway is an additional ANO10 function linked to SCAR10 aetiology. Further functional investigation is essential to unravel the ANO10 mechanism of action and involvement in disease development.

Indexed as

CalciumSpinocerebellar AtaxiasAnoctaminsDNA Repeat ExpansionHumansMembrane ProteinsANO10 protein, humanAnoctaminsCalciumMembrane ProteinsANO10AnoctaminAtaxiaSCAR10

Identifiers

PMID35648332
PMCPMC10126014
OpenAlexW4281608245

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.